Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome.

  • Authors : Ahn JS; Department of Hematology-Oncolgy, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea.; Kim YK

Subjects: Antimetabolites, Antineoplastic* ; Azacitidine*/Azacitidine*/Azacitidine*/administration & dosage ; Azacitidine*/Azacitidine*/Azacitidine*/adverse effects

  • Source: Acta haematologica [Acta Haematol] 2015; Vol. 134 (1), pp. 40-8. Date of Electronic Publication: 2015 Jun 06.Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662

Record details

×
Academic Journal

A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.

  • Authors : Jeong SH; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea.; Kim YJ

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*administration & dosage ; Azacitidine/Azacitidine/Azacitidine/*analogs & derivatives ; Myelodysplastic Syndromes/Myelodysplastic Syndromes/Myelodysplastic Syndromes/*drug therapy

  • Source: Oncotarget [Oncotarget] 2015 Dec 29; Vol. 6 (42), pp. 44985-94.Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients.

  • Authors : Kang JY; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-Daero, Seocho-Gu, Seoul, 137-701, Korea.; Ha JH

Subjects: Stem Cell Transplantation*/Stem Cell Transplantation*/Stem Cell Transplantation*/adverse effects; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*complications ; Lung Diseases/Lung Diseases/Lung Diseases/*complications

  • Source: International journal of hematology [Int J Hematol] 2015 May; Vol. 101 (5), pp. 505-13. Date of Electronic Publication: 2015 Feb 08.Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.

Subjects: Antimetabolites/Antimetabolites/Antimetabolites/*therapeutic use ; Azacitidine/Azacitidine/Azacitidine/*analogs & derivatives ; Azacitidine/Azacitidine/Azacitidine/*therapeutic use

  • Source: British journal of haematology [Br J Haematol] 2013 May; Vol. 161 (3), pp. 339-47. Date of Electronic Publication: 2013 Feb 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Feasibility of non-TBI conditioning with busulfan and fludarabine for allogeneic stem cell transplantation in lymphoid malignancy.

  • Authors : Shin HC; Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea.; Lee YJ

Subjects: Stem Cell Transplantation*/Stem Cell Transplantation*/Stem Cell Transplantation*/adverse effects ; Stem Cell Transplantation*/Stem Cell Transplantation*/Stem Cell Transplantation*/mortality; Busulfan/Busulfan/Busulfan/*therapeutic use

  • Source: The Korean journal of internal medicine [Korean J Intern Med] 2012 Mar; Vol. 27 (1), pp. 72-83. Date of Electronic Publication: 2012 Feb 28.Publisher: Korean Association of Internal Medicine Country of Publication: Korea (South) NLM ID: 8712418 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome.

  • Authors : Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ; Jang JH

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Azacitidine/Azacitidine/Azacitidine/*analogs & derivatives ; Myelodysplastic Syndromes/Myelodysplastic Syndromes/Myelodysplastic Syndromes/*drug therapy

  • Source: Haematologica [Haematologica] 2011 Oct; Vol. 96 (10), pp. 1441-7. Date of Electronic Publication: 2011 Jun 09.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

DNA methylation changes following 5-azacitidine treatment in patients with myelodysplastic syndrome.

  • Authors : Tran HT; Genome Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, Korea.; Kim HN

Subjects: Azacitidine/Azacitidine/Azacitidine/*pharmacology ; Azacitidine/Azacitidine/Azacitidine/*therapeutic use ; DNA Methylation/DNA Methylation/DNA Methylation/*drug effects

  • Source: Journal of Korean medical science [J Korean Med Sci] 2011 Feb; Vol. 26 (2), pp. 207-13. Date of Electronic Publication: 2011 Jan 24.Publisher: Korean Academy of Medical Science Country of Publication: Korea (South) NLM ID: 8703518 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment.

  • Authors : Moon JH; Department of Hematology/Oncology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 50 Samduck 2-Ga, Jung-Gu, 700-721 Daegu, South Korea.; Kim SN

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*administration & dosage ; Azacitidine/Azacitidine/Azacitidine/*administration & dosage ; L-Lactate Dehydrogenase/L-Lactate Dehydrogenase/L-Lactate Dehydrogenase/*blood

  • Source: Annals of hematology [Ann Hematol] 2010 Jul; Vol. 89 (7), pp. 681-9. Date of Electronic Publication: 2010 Mar 17.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine.

Subjects: Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Azacitidine/Azacitidine/Azacitidine/*therapeutic use ; Myelodysplastic Syndromes/Myelodysplastic Syndromes/Myelodysplastic Syndromes/*diagnosis

  • Source: Annals of hematology [Ann Hematol] 2010 Jan; Vol. 89 (1), pp. 15-23. Date of Electronic Publication: 2009 Jun 19.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  10 results for ""Kim YK""